Sixteen Healthcare Groups Make Major Commitments at 2nd Annual Patient Safety Rally in Taiwan
The Patient Safety Movement Foundation (PSMF) joined the Taiwan Patient Safety Culture Club (TPSCC) at the 2nd Annual Patient Safety Rally hosted by the TPSCC in Taichung, Taiwan on April 21, 2018. Sixteen healthcare organizations, including fourteen hospitals, committed to implementing the PSMF’s evidence-based Actionable Patient Safety Solutions (APSS), which have been proven to improve healthcare quality and eliminate preventable harm, and deaths, in hospitals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005360/en/
More than 150 attendees, including hospital executives and staff, attended this year's 2nd Annual Patient Safety Rally in Taiwan (Photo: Business Wire)
“I’ve said before that we must not hope for zero preventable patient deaths, we must plan for zero. We are thrilled by the leadership of Dr. Mingi Chan Liao M.D., Ph.D. and the Taiwan Patient Safety Culture Club who have rallied Taiwan’s hospitals to act on behalf of patients everywhere. Only through action will we be able to eliminate preventable harm from hospitals,” explained Joe Kiani, Founder, and Chairman of the Patient Safety Movement.
At the rally, Joe Kiani welcomed attendees with a short video. Each hospital’s leadership and executive staff took the stage to publicly announce their commitments to implement the APSS that, when implemented, will positively improve the care provided in their facilities. The list of committed hospitals and partners include:
1. Taichung Armed Forces General Hospital
2. Taitung Hospital
3. Chiayi Branch, Taichung Veterans General Hospital
4. Ministry of Health and Welfare Pingtung Hospital
5. Keelung Hospital Ministry of Health and Welfare
6. Taipei Hospital, Ministry of Health and Welfare
7. Jianan Psychiatric Center, Ministry of Health and Welfare
8. Hua-lien Hospital, Ministry of Health and Welfare
9. Pingtung Christian Hospital
10. St. Joseph’s Hospital
11. Tung's Taichung MetroHarbor Hospital
12. Penghu Hospital, Ministry of Health and Welfare
13. Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
14. Changhua Christian Children’s Hospital
15. Committed Partner: Taiwan Healthcare Quality Association
16. Committed Partner: Unison Healthcare Group
Also speaking at the rally were Ms. Maria Cvach, the director of Policy Management and Integration at Johns Hopkins Hospital and Dr. Shin Ushiro, a professor of safety management at Kyushu University Hospital, Japan. The Patient Safety Movement Foundation’s Vice President, Ariana Longley, was on hand to support the work being done by the TPSCC, as one of the PSMF’s most active committed partners internationally. More than 120 supporters attended the rally as the Taiwan Patient Safety Culture Club works to join the PSMF in unifying the healthcare ecosystem.
“To improve patient safety, we must not only listen but act. I am thrilled by the commitment of all sixteen committed hospitals and partners who have shown great leadership by implementing evidence-based processes proven to improve patient safety. The combined commitments from our two rallies means that 19 out of 22 administrative regions have embraced patient safety with the commitment to ZERO preventable deaths by 2020,” explained Dr. Chan Liao.
Following the rally, Ms. Longley joined the Club’s President, Dr. Chan Liao, for visits to local hospitals. The rally is the second in the last year by Taiwan’s hospitals to raise awareness and take action to improve patient safety in hospitals. Last year, 19 Taiwanese hospitals made commitments to implementing APSS.
For more information on the rally or the Patient Safety Movement Foundation, please visit patientsafetymovement.org or contact Tanya Lyon, Public Relations Manager at (949) 351-2858 or email@example.com.
About Patient Safety Movement Foundation:
More than 200,000 U.S. patients and three million worldwide die each year from preventable causes. The Patient Safety Movement Foundation (PSMF) was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to zero by 2020 (0X2020). Improving patient safety requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The PSMF works with all stakeholders to address problems with actionable solutions. The Foundation also convenes the World Patient Safety, Science and Technology Summit bringing together some of the world’s best minds for thought-provoking discussions and new ideas that challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
Patient Safety Movement Foundation
Tanya Lyon, 949-351-2858
Public Relations Manager
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 21:00 | Tiedote
Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 17:33 | Tiedote
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W
Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 16:55 | Tiedote
Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’
Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 16:15 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk
Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease16.11.2018 15:57 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, lumacaftor/ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF for patients aged 2 to 5 years old who have two copies of the F508del mutation. “Cystic fibrosis is a chronic, progressive disease and it is important to treat early to ensure the best possible outcomes for patients,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. “Today’s announcement brings us one step cl
Dimension Data Global Delivery Centre (GDC) in Prague wins the ABSL 2018 Diamond Award for Business Innovation16.11.2018 11:00 | Tiedote
Dimension Data, the USD 8 billion global technology integrator and managed services provider, today announced that its Global Delivery Centre (GDC) in Prague has won the 2018 ABSL Diamond award for Business Innovation. The main purpose of this centre is to provide innovative, global service delivery capabilities and deep technical expertise to support our clients. The ABSL Diamond awards recognise companies that implement innovative projects, enhancing their business and strengthening the position of the business services sector. Every year, the aim is to identify successful activities in this sector and promote best practices, ultimately encouraging and inspiring others to follow suit. The ABSL celebrates initiatives that push business services forward and stand out as exemplary projects. Bill Padfield, Group Chief Operating Officer for Transformation and Services at Dimension Data, said: “Winning another award for our Support Services is a fantastic achievement. This time the ABSL Di
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme